Prioritize your compounds
for mammalian studies
We offer custom high throughput screening services in humanized worm disease models. We employ microfluidic automation and distributed imaging to perform whole-life screening of thousands of compounds. We harness data-intelligence tools to provide phenotypic information related to changes in the neuromuscular system, behavior, reproductive system, healthspan and lifespan. Such comprehensive information will enable you to prioritize costly drug studies in mammalian models.
About 250 human disease-causing genes can be modeled in C. elegans. Here are some examples of disease models in which we offer services.
Our Approach Offers
Our data analysis pipeline gives tissue-level and organism-level insights that will be critical for our customers to assess compound bioavailability and toxicity prior to costly and time-consuming mammalian studies.